Lecanemab en la enfermedad de Alzheimer: ¿realmente estamos ante un cambio en el pronóstico de la enfermedad? / Lecanemab in Alzheimer's disease: are we really facing a change in the prognosis of the disease?
Rev. neurol. (Ed. impr.)
; 76(6): 185-188, Mar 16, 2023.
Article
in Es
| IBECS
| ID: ibc-217462
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
Full text:
1
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Biomarkers
/
Dementia
/
Alzheimer Disease
/
Antibodies, Monoclonal
Limits:
Aged
/
Humans
Language:
Es
Journal:
Rev. neurol. (Ed. impr.)
Year:
2023
Document type:
Article